IntraLase Schedules First Quarter Conference Call for Thursday, April 27, 2006

IntraLase(R) Corp. (NASDAQ:ILSE) announced today that itwill report its 2006 first quarter results on Thursday, April 27,2006. A news release will be issued and will also be posted on thecompany's Web site at www.intralase.com. Also on April 27, IntraLasewill hold an investor conference call at 11 a.m. Eastern time todiscuss the company's results. Hosting the call will be Robert J.Palmisano, president and chief executive officer, and Shelley B.Thunen, executive vice president and chief financial officer. Membersof the news media may "listen only" to the conference call.

The conference call will be webcast live and can be accessed onthe IntraLase Web site. The webcast is available to both institutionaland individual investors. Individual investors can access the webcastat: www.fulldisclosure.com. Institutional investors can access thewebcast via a password-protected event-management site atwww.streetevents.com. The live call may also be accessed by telephoneat 866-825-3354 or for international parties at 617-213-8063 andentering the confirmation code 16974298 between 10:50 a.m. and 11 a.m.Eastern time. The webcast will be archived and available for replayuntil 5 p.m. Pacific time on May 4, 2006. A telephone rebroadcast ofthe call may be accessed April 27, 2006, beginning at 1 p.m. Easterntime for a one-week period by calling 888-286-8010 or forinternational parties 617-801-6888 and entering confirmation code18731904.

About IntraLase Corp.

IntraLase designs, develops, and manufactures an ultra-fast laserthat is revolutionizing refractive and corneal surgery by creatingsafe and more precise corneal incisions. Delivering on the promise ofophthalmic laser technology, the IntraLase FS laser, related software,and disposable devices replace the hand-held microkeratome blade usedduring LASIK surgery. The unsurpassed accuracy of IntraLase'scomputer-controlled femtosecond laser has been shown to improve safetyprofiles and visual outcomes when used during LASIK. Additionally, theIntraLase FS laser creates precision-designed intracorneal incisionsthat when combined can be used during lamellar and penetratingkeratoplasties and intrastromal ring implantation. IntraLase ispresently in the process of commercializing applications of itstechnology in the treatment of corneal diseases that require cornealtransplant surgery. The company's proprietary laser and disposablepatient interfaces are presently marketed throughout the United Statesand 26 other countries. IntraLase has headquarters and manufacturesits products in Irvine. For additional information, visit thecompany's Web site: www.intralase.com.